Rchr
J-GLOBAL ID:201901015577993150   Update date: Jan. 30, 2024

Sato Tomoo

Sato Tomoo
Affiliation and department:
Research field  (1): Neurology
Research theme for competitive and other funds  (5):
  • 2020 - 2025 Japan-Australia joint study for epidemiological survey of HTLV-1 a/c subtypes and elucidation of their unique pathogenic mechanims
  • 2019 - 2022 Study on optimization of anti-CCR4 antibody therapy for patients with HTLV-1-associated myelopathy
  • 2016 - 2019 Developmental mechanism of regulatory T cell-derived abnormal T cells identified by HAM
  • 2013 - 2016 Pathogenicity of Treg-derived Th1-like cells identified in patients with HTLV-1-associated myelopathy
  • 2010 - 2012 Study of novel factor, SPACIA1 which is expressed in synovial tissue in rheumatoid arthritis.
Papers (92):
  • Naoki Takao, Tomoo Sato, Junji Yamauchi, Naoko Yagishita, Erika Horibe, Yoshihisa Yamano. [National Questionnaire Survey on the Actual Use and Content Evaluation of the human T-cell leukemia virus type I (HTLV-1) -associated Myelopathy (HAM) Practice Guidelines 2019]. Rinsho shinkeigaku = Clinical neurology. 2023. 63. 7. 433-440
  • Tomoo Sato, Junji Yamauchi, Naoko Yagishita, Natsumi Araya, Naoki Takao, Yuki Ohta, Eisuke Inoue, Masaki Takahashi, Makoto Yamagishi, Yutaka Suzuki, et al. Long-term safety and efficacy of mogamulizumab (anti-CCR4) for treating virus-associated myelopathy. Brain : a journal of neurology. 2023
  • M.D., Ph.D. Takao Naoki, M.D., Ph.D. Sato Tomoo, M.D., Ph.D. Yamauchi Junji, Yagishita Naoko, Horibe Erika, M.D., Ph.D. Yamano Yoshihisa. National Questionnaire Survey on the Actual Use and Content Evaluation of the human T-cell leukemia virus type I (HTLV-1) -associated Myelopathy (HAM) Practice Guidelines 2019. Rinsho Shinkeigaku. 2023. 63. 7. 433-440
  • Hirofumi Matsumoto, Makoto Shiraishi, Ariaki Higashi, Sakae Hino, Mayumi Kaburagi, Heisuke Mizukami, Futaba Maki, Junji Yamauchi, Kenichiro Tanabe, Tomoo Sato, et al. The Forward and Lateral Tilt Angle of the Neck and Trunk Measured by Three-Dimensional Gait and Motion Analysis as a Candidate for a Severity Index in Patients with Parkinson's Disease. Neurology international. 2022. 14. 3. 727-737
  • Yusaku Wada, Tomoo Sato, Hiroo Hasegawa, Takahiro Matsudaira, Naganori Nao, Ariella L G Coler-Reilly, Tomohiko Tasaka, Shunsuke Yamauchi, Tomohiro Okagawa, Haruka Momose, et al. RAISING is a high-performance method for identifying random transgene integration sites. Communications biology. 2022. 5. 1. 535-535
more...
MISC (48):
more...
Patents (3):
Lectures and oral presentations  (49):
  • マウスコラーゲン誘導関節炎の重症度の違いにおけるSPACIA1/Saal1遺伝子欠損の影響
    (日本リウマチ学会総会・学術集会プログラム・抄録集 2019)
  • HAMの急速進行例におけるメチルプレドニゾロンパルス療法後の維持療法の評価
    (臨床神経学 2018)
  • 腎移植患者のHTLV-1関連疾患発症に関する全国調査
    (NEUROINFECTION 2018)
  • HAM治療薬としての抗CCR4抗体製剤(モガムリズマブ)
    (NEUROINFECTION 2018)
  • HAM患者レジストリ「HAMねっと」の運営
    (NEUROINFECTION 2018)
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page